Cargando…
miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway
INTRODUCTION: Prostate cancer (PCa) is one of the most common malignancies, and almost all patients with advanced PCa will develop castration-resistant prostate cancer (CRPC) after receiving endocrine therapy. Effective treatment for patients with CRPC has not been established. Novel approaches are...
Autores principales: | Zhao, Jiafu, Xu, Houqiang, Duan, Zhiqiang, Chen, Xiang, Ao, Zheng, Chen, Yinglian, Ruan, Yong, Ni, Mengmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402864/ https://www.ncbi.nlm.nih.gov/pubmed/32801901 http://dx.doi.org/10.2147/CMAR.S247780 |
Ejemplares similares
-
miR-29b-3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL-2 regulatory axis
por: Zhao, Jiafu, et al.
Publicado: (2022) -
miR-27b-3p and miR-607 cooperatively regulate BLM gene expression by directly targeting the 3′-UTR in PC3 cells
por: Chen, Yinglian, et al.
Publicado: (2019) -
Bcl-2 Is Involved in Cardiac Hypertrophy through PI3K-Akt Pathway
por: Meng, Xianwei, et al.
Publicado: (2021) -
Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells
por: Chen, Kun, et al.
Publicado: (2019) -
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
por: Fan, Ming-De, et al.
Publicado: (2020)